Literature DB >> 17550970

The retromer component sorting nexin-1 is required for efficient retrograde transport of Shiga toxin from early endosome to the trans Golgi network.

Miriam V Bujny1, Vincent Popoff, Ludger Johannes, Peter J Cullen.   

Abstract

The mammalian retromer complex is a multi-protein complex that regulates retrograde transport of the cation-independent mannose 6-phosphate receptor (CI-MPR) from early endosomes to the trans Golgi network (TGN). It consists of two subcomplexes: a membrane-bound coat comprising sorting nexin-1 (SNX1) and possibly sorting nexin-2 (SNX2), and a cargo-selective subcomplex, composed of VPS26, VPS29 and VPS35. In addition to the retromer, a variety of other protein complexes has been suggested to regulate endosome-to-TGN transport of not only the CI-MPR but a wide range of other cargo proteins. Here, we have examined the role of SNX1 and SNX2 in endosomal sorting of Shiga and cholera toxins, two toxins that undergo endosome-to-TGN transport en route to their cellular targets located within the cytosol. By using small interfering RNA (siRNA)-mediated silencing combined with single-cell fluorescent-toxin-uptake assays and well-established biochemical assays to analyze toxin delivery to the TGN, we have established that suppression of SNX1 leads to a significant reduction in the efficiency of endosome-to-TGN transport of the Shiga toxin B-subunit. Furthermore, we show that for the B subunit of cholera toxin, retrograde endosome-to-TGN transport is less reliant upon SNX1. Overall, our data establish a role for SNX1 in the endosome-to-TGN transport of Shiga toxin and are indicative for a fundamental difference between endosomal sorting of Shiga and cholera toxins into endosome-to-TGN retrograde transport pathways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17550970     DOI: 10.1242/jcs.003111

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  57 in total

1.  AGAP2 regulates retrograde transport between early endosomes and the TGN.

Authors:  Yoko Shiba; Winfried Römer; Gonzalo A Mardones; Patricia V Burgos; Christophe Lamaze; Ludger Johannes
Journal:  J Cell Sci       Date:  2010-06-15       Impact factor: 5.285

2.  A Conserved Structural Motif Mediates Retrograde Trafficking of Shiga Toxin Types 1 and 2.

Authors:  Andrey S Selyunin; Somshuvra Mukhopadhyay
Journal:  Traffic       Date:  2015-11-02       Impact factor: 6.215

Review 3.  Retrograde transport of protein toxins through the Golgi apparatus.

Authors:  Kirsten Sandvig; Tore Skotland; Bo van Deurs; Tove Irene Klokk
Journal:  Histochem Cell Biol       Date:  2013-06-14       Impact factor: 4.304

4.  Clathrin is not required for SNX-BAR-retromer-mediated carrier formation.

Authors:  Ian J McGough; Peter J Cullen
Journal:  J Cell Sci       Date:  2012-09-26       Impact factor: 5.285

Review 5.  Emerging Role of Retromer in Modulating Pathogen Growth.

Authors:  Cherilyn Elwell; Joanne Engel
Journal:  Trends Microbiol       Date:  2018-04-24       Impact factor: 17.079

6.  Retrograde Shiga toxin trafficking is regulated by ARHGAP21 and Cdc42.

Authors:  Heidi Hehnly; Katrina Marie Longhini; Ji-Long Chen; Mark Stamnes
Journal:  Mol Biol Cell       Date:  2009-08-19       Impact factor: 4.138

Review 7.  Retromer.

Authors:  Juan S Bonifacino; James H Hurley
Journal:  Curr Opin Cell Biol       Date:  2008-05-09       Impact factor: 8.382

8.  Rab9-dependent retrograde transport and endosomal sorting of the endopeptidase furin.

Authors:  Pei Zhi Cheryl Chia; Isabelle Gasnereau; Zi Zhao Lieu; Paul A Gleeson
Journal:  J Cell Sci       Date:  2011-06-21       Impact factor: 5.285

Review 9.  Shiga toxins--from cell biology to biomedical applications.

Authors:  Ludger Johannes; Winfried Römer
Journal:  Nat Rev Microbiol       Date:  2009-12-21       Impact factor: 60.633

10.  The retromer coat complex coordinates endosomal sorting and dynein-mediated transport, with carrier recognition by the trans-Golgi network.

Authors:  Thomas Wassmer; Naomi Attar; Martin Harterink; Jan R T van Weering; Colin J Traer; Jacqueline Oakley; Bruno Goud; David J Stephens; Paul Verkade; Hendrik C Korswagen; Peter J Cullen
Journal:  Dev Cell       Date:  2009-07       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.